
Pharmaceutical giant Johnson & Johnson is set to sell several of its prescription medications through the TrumpRx platform, a US government-linked website designed to lower drug prices for patients.
The move is part of a broader cost-cutting agreement between major drugmakers and the Trump administration aimed at making medicines more affordable.